loader2
Partner With Us NRI

Company details

86.55
90.95
68.85
154.85
6M Return 17.81%
1Y Return -38.14%
Mkt Cap.(Cr) 98.02
Volume 131
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 131

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 21.44 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 22,733.13 -38,406.68
LAST 3M 72,017.19 -50,293.88
LAST 6M 138,790.76 -188,500.14
LAST 12M 206,712.84 -177,545.72

Information

  • About Company
  • Company Info
  • Listing Info
45.02
73.5%
20.5922
15.73%
12.69%
Description
  • Arvee Laboratories (India) Limited was incorporated as a private limited company with the name `Arvee Laboratories (India) Private Limited` on January 27, 2012 in Ahmedabad, Gujarat. Subsequently, the name of the company was changed to Arvee Laboratories (India) Limited pursuant to conversion into a public company onSeptember 19, 2017. Initially, the control & management of the Company was with Mr. Bharat Rasiklal Chokshi, Mr Saumil Bharatbhai Chokshi, Mr. Sudhakarbhai Chhotabhai Patel and Mr. Shalin Bharat Chokshi who were the subscribers to the Memorandum of Association. Since, April 01, 2013 the control & management was completely taken over by Mr. Shalin Sudhakarbhai Patel and Mr. Shalin Bharat Chokshi. The Company started its work by trading in specialty chemicals by getting manufacturing done on job work basis from Skylead Chemicals Limited and Skylink Chemicals Private Limited. On April 20, 2013, the company bought land, building and machineries from Skylink Chemicals Private Limited who were engaged in manufacturing of specialty chemicals which fostered its growth and expansion. Since 2013 the Company hasbeen making additions to its plant & machinery, expanding capacities and modernizing its building. The Company started its operations with an aim to become a leader & front runner in chemical industry by providing the best and innovative quality chemical products. Keeping quality and precision as the benchmark for any operation, Arvee hails to become the most sought after chemical manufacturing company offering good products at reasonable price. Quality, Service and Advancement are the mainstay of the Company. From humble beginnings, Arvee has carved a niche presence in the chemical industry in a very short span.

Read More

Registered Address

49/3 B Shyamal Row House, 100 Feet Road Satelitte, Ahmedabad, Gujarat, 380015

Tel : 91-79-26749036/37/38
Email : shalin.patel:arveelabs.com
Website : http://www.arveelabs.com

Registrar

Bigshare Services Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 535050
NSE Code : ARVEE
Book Closure Date (Month) : Sep
BSE Group :
ISIN : INE006Z01016

ICICIdirect Arvee Laboratories (India) Ltd FAQ

You can buy Arvee Laboratories (India) Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Arvee Laboratories (India) Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 25, 2022 02:58 PM the closing price of Arvee Laboratories (India) Ltd was ₹ 88.95.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 25, 2022 02:58 PM, the market cap of Arvee Laboratories (India) Ltd stood at ₹ 98.02.
The latest PE ratio of Arvee Laboratories (India) Ltd as of May 25, 2022 02:58 PM is 45.02
The latest PB ratio of Arvee Laboratories (India) Ltd as of May 25, 2022 02:58 PM is 0.23
The 52-week high of Arvee Laboratories (India) Ltd is ₹ 154.85 while the 52-week low is ₹ 68.85 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE